Mirum Pharmaceuticals Inc (MIRM) — Long-term Investment Intensity
Mirum Pharmaceuticals Inc (MIRM) has a Long-term Investment Intensity of 3.9% as of March 2026. Long-term investments of $34.35 Million represent 3.9% of total assets of $890.92 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Mirum Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Mirum Pharmaceuticals Inc Long-term Investment Intensity (2019–2025)
This chart shows how Mirum Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2019 to 2025. As of March 2026, the intensity stands at 3.9%, reflecting long-term investments of $34.35 Million against total assets of $890.92 Million USD. Also explore Mirum Pharmaceuticals Inc asset portfolio for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Mirum Pharmaceuticals Inc (2019–2025)
The table below presents the year-by-year Long-term Investment Intensity for Mirum Pharmaceuticals Inc from 2019 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see MIRM company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.0% | $8.11 Million | $842.81 Million | ▼ -0.9 pp |
| 2024 | 1.9% | $12.53 Million | $670.75 Million | ▲ +0.2 pp |
| 2021 | 1.7% | $4.98 Million | $294.65 Million | ▼ -14.2 pp |
| 2019 | 15.9% | $23.29 Million | $146.71 Million | — |